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ABSTRACT
Objective: To evaluate the impact of avoidable mortality
on the changes in life expectancy at birth in Spain.
Methods: Standard life table techniques and the Arriaga
method were used to calculate and to decompose life
expectancy (LE) changes by age, effects and groups of
causes of avoidable mortality among three periods (1987–
91, 1992–6 and 1997–2001). A list of causes of avoidable
mortality reached by consensus and previously published
in Spain was used.
Main results: Life expectancy increased in all ages and
both sexes. The main contribution to the increase of LE at
birth was due to people over 50. Mortality in young adults
produced a reduction in LE between the first two periods,
but there was an important increase in LE between the
last two periods; in both cases, this was the result of
factors amenable to health policy interventions. The
highest improvement in LE was due to non-avoidable
causes, but avoidable mortality through health service
interventions showed improvements in LE in those
younger than 1 year and in those aged 45–75 years.
Conclusions: Making a distinction between several
groups of causes of avoidable mortality and using
decomposition by causes, ages and effects allowed us to
better explain the impact of avoidable mortality on the LE
of the whole population and gave a new dimension to this
indicator that could be very useful in public health.
Avoidable mortality has been proposed as an
indicator to monitor health service results
12and
to compare the performance of different health
systems. In the field of public health and health
services research, much work has been previously
published
34although its use in practice has not yet
become generalised. In Spain, this indicator was
introduced at the beginning of the 1990s under the
acronym MIPSE (Unnecessarily Premature and
Amenable to Health Services Mortality),
5 and an
atlas with the distribution of avoidable mortality
in autonomous communities was published
6 that
has been used in several studies and health
reports.
78
The indicator of avoidable mortality is based on a
selection of deaths that, according to the cause of
death and age, should not have occurred because
health measures exist that should have been
sufficiently effective to avoid them.
12 Empirical
studies analysing this indicator in different coun-
triesandoverdifferenttimeperiodsshowconsistent
results which are compatible with the concept on
which the indicator is based.
4 In other words, time
trends of avoidable mortality are more favourable
than those of mortality that is considered to be
non-avoidable or general. The geographical distribu-
tion of avoidable mortality is related to differences
in socioeconomic status, the level of development of
the country and, especially, the development of a
country’s health system.
34 Some authors have
distinguished between subgroups of causes of
avoidable mortality to indicate the effects of
different kinds of health interventions: primary or
secondary prevention or treatment.
39
Within the limitations, the most important is the
variability among studies of the different causes of
deaths that are considered to be avoidable
41 0 .A
recent study showed that geographical variation and
differences in time trends of avoidable mortality are
very highly dependent on which causes of death are
considered to be avoidable, as this can produce
contradictory or inconsistent results.
11 To counter-
act this problem and to make studies in Spain more
consistent, a group of experts has updated the
avoidable mortality list through a consensus pro-
cess.
12 Using this new list, the performance of the
Spanish health system within autonomous commu-
nities has been analysed.
8 The results showed that in
the last 15 years avoidable mortality has decreased
more than non-avoidable mortality, and particularly
so for those causes of death that are influenced by
the direct intervention of the healthcare system.
13 In
contrast, those causes of death that are influenced
mainlybythepolicymeasurestakeninothersectors,
which nevertheless have an impact on health,
showed fluctuating results (initially there was an
increase but this was followed by a decrease in
deaths).
13 Furthermore, the geographical pattern is
also different for both groups of causes of death,
withavoidable mortalityduetocausesinfluencedby
healthcare being higher in the south of Spain and
avoidable mortality due to causes influenced by
health policy interventions being higher in regions
along the Mediterranean coast.
13
The objective of this work was to evaluate the
impact of avoidable mortality on the health status
of the general population by analysing the effect
that avoidable mortality has had on the evolution
of life expectancy (LE) at birth in Spain.
METHODS
Deaths of residents in Spain from 1987 to 2001 and
estimations of the inter-census populations on 1
July each year from 1987 to 2001 were used.
14
The analysis was carried out for groups of
causes, according to the list reached by consensus
and previously published in Spain
12 (table 1). The
groups were: global avoidable mortality including
all deaths on the list; avoidable mortality through
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intersectoral health policy interventions; and the remaining
causes of death, which we called non-avoidable. The consensus
process involved experts in medical specialties and public health
and followed several criteria to update the already published
lists of avoidable mortality. The most important were the
availability in Spain of effective measures to treat or prevent the
listed diseases; the increase in the upper age limit to fit with the
important increase in life expectancy experienced; and that
accidents and violence were considered to be preventable, which
is how they are considered in the public health field.
12
Life expectancy at birth has been calculated according to
standard life table techniques, with 85 and older being the last
age group. The impact of avoidable mortality on the change of
life expectancy at birth between time periods was estimated by
decomposing life expectancy. Decomposition of differences in
life expectancy was undertaken using the method developed by
Arriaga
15 with free software (Epidat 3.0) developed by the
Regional Ministry of Health in Galicia, Spain, and the Pan
American Health Organization.
16
This method enables the separation of differences in life
expectancy into factors related to age and cause of death, or to
age and effects, expressed in years gained or lost. There are three
additive effects:
c direct effect: years of life gained in the age group x, x+n owing
to the mortality changes in the group itself
c indirect effect: years of life gained after the age x+n because of
an increased number of survivors (as a result of the
Table 1 Groups of causes of avoidable mortality in the Spanish consensus list (from Gispert et al.
12)
Condition Age ICD-9 codes ICD-10 codes
Mortality avoidable by health service interventions
Tuberculosis (sequelae included) 0–74 010–018,137 A15–A19, B90
Cervical cancer 15–74 180 C53
Cancer of corpus uteri and cancer of unspecified
part of uterus
15–74 182,179 C54, C55
Hodgkin’s disease 0–74 201 C81
Chronic rheumatic heart diseases 0–74 393–398 I05–I09
Pneumonia, acute respiratory infections and influenza 0–74 480–486, 460–466, 487 A48.1, J12–J18 (except J18.2), J00–J06
(except J02.0, J03.0), J20–J22, J10–J11
Asthma 5–49 493 J45–J46
Diseases of the appendix 0–74 540–543 K35–K38
Abdominal hernia 0–74 550–553 K40–K46
Cholelithiasis/cholecystitis 0–74 574–575 K80–K82
Hypertensive diseases 0–74 401–405 I10–I15
Cerebrovascular diseases 0–74 430–438 I60–I69, G45, F01.1
Maternal mortality (pregnancy, childbirth and puerperal
complications)
All ages 630–676 O00–O99, A34
Perinatal conditions All ages 760–779 P00–P96, A33
Female breast cancer 0–74 174 C50 (female)
Ischaemic heart diseases 35–74 410–414 I20–I25
Peptic ulcer 0–74 531–534 K25–K28
Immunisation preventable 0–74 032, 037, 033, 055, 056, 072, 045,
070.0, 070.1, 070.2–70.3
A36, A35, A37, A49.2, B05, B06, B26, A80, B15,
B16, B17.0, B18.0–B18.1
Nutritional anaemias 0–74 280–281 D50–D53
Cancer of skin (melanoma and non-melanoma) 0–74 172, 173 C43, C44, C46.0, C46.9
Cancer of testis 0–74 186 C62
Leukaemia ,15 204–208 C91–C95
Disorders of the thyroid gland 0–74 240–246 E00–E07
Diabetes mellitus 0–49 250 E10–E14
Hyperplasia of the prostate 0–74 600 N40
Congenital malformations of the circulatory system 0–74 745–747 Q20–Q28, I51.0
Adverse events during surgical and medical procedures All ages E870–879 Y60–Y84
Mortality avoidable by health policy interventions
Cancer of trachea, bronchus and lung 0–74 162 C33, C34
Alcoholic liver disease 15–74 571.0–571.3 K70.0, K70.1, K70.2–K70.3, K70.4, K70.9
AIDS and HIV disease All ages 279.5, 042, 279.6, 795.8* B20–24, R75
Traffic accident involving a motor vehicle All ages E810–825 V02–V04, V09 (except V09.1 and V09.9), V12–
V14, V19.0–V19.2, V19.4–V19.6, V20–V79,
V80.3–V80.5, V81.0–V81.1, V82.0–V82.1, V83–
V88 (except V88.9), V89 (except V89.1)
Suicide All ages E950–959 X60–X84, Y87.0
Homicide All ages E960–969 X85–Y09, Y87.1
Remainder of external causes (excludes traffic
accidents involving a motor vehicle, suicide,
homicide and iatrogenic causes)
All ages E800–807
E826–849
E850–858
E860–869
E880–949
E970–999
V01, V05–V06, V09.1, V09.9, V10–V11, V15–
V18, V19.3, V19.8–V19.9, V80.0–V80.2, V80.6–
V80.9, V81.2–V81.9, V82.2–V82.9, V88.9, V89.1,
V90–V99, W00–W99, X00–X49, X50–X59, Y10–
Y59, Y85–Y86, Y87.2, Y88–Y89, F10.0
*When this disease was first recognised, different codes were used in several regions of Spain.
ICD, International Classification of Diseases.
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mortality of the older age groups does not change)
c interaction: years of life gained because of the supplementary
survivors at age x+n as a consequence of mortality changes
between x and x+n, taking into account that the mortality
in the higher age groups also changes.
The open-ended age group (85 and over) is influenced only by
a direct effect. The main difference between a direct effect and
the other effects is that a direct effect measures the effect on LE
that mortality changes in one age group produce in the group
itself. Indirect and interaction effects measure the differences on
LE that the mortality changes in one group produce through
other age groups. See the supplementary material for further
information on the calculations that were carried out.
The data were grouped into three periods of 5 years (P1,
1987–91; P2, 1992–6; P3, 1997–2001) to increase their consis-
tency. The periods were chosen to fit as far as possible the LE
trends experienced in Spain. Life tables for each one of the
periods and for each sex were computed. For each change
between two periods, the contribution of the groups of causes
of mortality and of the effects by age and sex on the LE
differences were analysed.
RESULTS
The total number of avoidable deaths analysed was 1 023 036,
which is 20% of the total mortality in the whole period (10.96%
due to causes affected by health service interventions and 9.04%
to causes avoidable by health policy actions). Non-avoidable
causes accounted for the largest number of deaths and increased
proportionally from one period to another (P1, 78.7%; P2, 79.42%;
P3, 81.74%), whereas deaths due to avoidable causes decreased
(P1, 21.3%; P2, 20.58%; P3, 18.25%) in relation to the total deaths
in each period. There was a higher number of avoidable deaths in
men than in women (25.86% versus 13.49%).
Figure 1 shows the changes in life expectancy, in number of
years, by age and for both sexes between the analysed periods.
Between the two first periods (P1 and P2) there is a greater
increase in life expectancy at birth and at all ages in women.
Men aged from 25 to 34 show the smallest increase. Between
the next two periods (P2 and P3) the increase is higher in men,
about 1.5 years, up to the age of 24 years, and in women the
difference is around 1 year. In the older than 50 age group, the
increase in life expectancy is similar in both sexes.
Table 2 shows the contribution of the three different effects
to the changes in LE at birth, according to age group. Although
LE was calculated in 5-year age groups with an open-ended
group for age 85 and over, the results are presented for wider age
groups to facilitate legibility. In both sexes the contribution to
the increase of LE at birth in the age groups over 50 is notable.
Furthermore, between periods P1 and P2 the mortality of 25–49-
year-old men produced a reduction in LE, but between periods
P2 and P3 there was an important increase in LE for men. With
regard to the three different effects, for all ages and in both
sexes, the most important contribution is due to the indirect
Figure 1 Differences in life expectancy
by sex and age between the periods P1
and P2 and between the periods P2 and
P3; Spain 1987–2001.
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first and second periods is shown for all of the effects. Direct
effects are observed in all groups, but they are much more
important after the age of 50.
In figures 2 and 3 the contribution of causes and ages to the
years of LE gained at birth, in number of years, is shown. It is
evident that the highest number of years gained in both sexes is
due to non-avoidable causes, mostly because of the contribution
of ages older than 75, particularly in women, although in the
last period the effect of avoidable causes is higher. The negative
contribution of young people between the first two periods is
basically a result of the mortality due to causes that can be
affected by health policies in both sexes, but mainly in men.
Nevertheless, between the second and third periods, these
causes showed important gains in years of LE at birth for men.
Finally, avoidable causes through health service interventions
showed gains in LE in the groups younger than 1; the young and
middle-aged population, especially in men; and the elderly,
mainly in women.
DISCUSSION
There has been an important increase in life expectancy at birth
in Spain over the last 20 years, although during this time the
improvement has not been consistent. The increase reflects the
epidemiological profile of events affecting population health.
For this reason it is very important to be able to identify the role
that age and causes of death have played in this improvement,
especially those causes that could be modified by available
means.
Among the results, the negative impact on LE of causes
amenable to health policies stands out, mainly in young age
groups, between the first and second periods analysed. This is
due to a combination of well-known factors that in recent years
have threatened public health in Spain. There has been an
increase in mortality for the younger age groups because of
AIDS, drugs and traffic accidents,
17 all of which are causes that
are included in the group of avoidable mortality through
intersector health policy interventions. The mortality from
these causes was considerably reduced from the second to the
third period as a result of the improvements in treatments for
AIDS and a drastic reduction in the consumption of more lethal
drugs and in traffic accidents.
18 19 As a result, these causes of
death are among the highest contribution to the increase in LE.
Within the avoidable mortality through health services
interventions group, a positive effect on LE stands out in the
younger than 1 year age group as a consequence of the
improvement in perinatal and neonatal mortality. Also in the
age groups from 50 to 75 there is a positive effect because of a
reduction in mortality due to cerebrovascular diseases, other
heart diseases, respiratory and digestive diseases and female
breast cancer, as shown in other studies on avoidable
mortality.
41 02 0The improvement in mortality rates as a result
of these diseases has been noted in different studies of mortality
trends in Spain, and it has been attributed to a beneficial effect
of the treatment and control of cardiovascular and respiratory
risk factors and to the improvement in medical treat-
ments.
17 21 22
Nevertheless, the results also show an apparent paradox
because non-avoidable causes of death seem to be producing the
highest gains in LE. One explanation could be the significant
contribution that non-avoidable causes make to the total
number of deaths. However, if the results are viewed in relative
terms, they show a different effect: a reduction of one-quarter
of the total deaths produces around half of the years gained,
Table 2 Contribution of the three different effects to the differences in life expectancy at birth by age and time period; Spain 1987–2001
Period Effect
Males
0–24 25–49 50–84 >85 Total
N % N% N% N% N%
1987–91 to 1992–6 Direct effect 0.0114 3.10 20.0113 5.90 0.1124 19.09 0.0286 100 0.1411 17.80
Indirect effect 0.3527 96.03 20.1776 92.74 0.4605 78.24 – – 0.6356 80.17
Interaction 0.0029 0.79 20.0026 1.36 0.0158 2.68 – – 0.0161 2.03
Total 0.3673 100 20.1916 100 0.5885 100 0.0286 100 0.7928 100
1992–96 to 1997–2001 Direct effect 0.0076 2.66 0.0347 5.96 0.1441 18.25 20.0053 100 0.1811 10.96
Indirect effect 0.2722 95.11 0.5334 91.59 0.6258 79.26 – – 1.4314 86.60
Interaction 0.0062 2.17 0.0143 2.45 0.0198 2.50 – – 0.0403 2.44
Total 0.2862 100 0.5824 100 0.7895 100 20.0053 100 1.6528 100
Period Effect
Females
0–24 25–49 50–84 >85 Total
N % N% N% N% N%
1987–91 to 1992–6 Direct effect 0.0048 2.20 0.0000 0.00 0.1470 18.32 0.1264 100 0.2782 24.45
Indirect effect 0.2103 96.51 20.0089 101.14 0.6254 77.93 – – 0.8268 72.65
Interaction 0.0029 1.33 0.0001 21.14 0.0300 3.74 – – 0.0330 2.90
Total 0.2179 100 20.0088 100 0.8025 100 0.1264 100 1.1380 100
1992–96 to 1997–2001 Direct effect 0.0035 2.00 0.0081 5.14 0.1032 17.93 0.0577 100 0.1725 17.86
Indirect effect 0.1697 96.92 0.1471 93.40 0.4600 80.00 – – 0.7768 80.41
Interaction 0.0019 1.09 0.0023 1.46 0.0125 2.17 – – 0.0167 1.73
Total 0.1751 100 0.1575 100 0.5757 100 0.0577 100 0.9660 100
N, total number of years due to the corresponding effect in each age group.
Direct effect, years of life gained in the age group x, x+n owing to the mortality changes in the group itself.
Indirect effect, years of life gained after the age x+n because of an increased number of survivors (as a result of the mortality changes of the age group x, x+n, assuming that the
mortality of the older age groups does not change).
Interaction, years of life gained because of the supplementary survivors at age x+n as a consequence of mortality changes between x and x+n, taking into account that the mortality
in the higher age groups also changes.
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avoidable causes results in the highest number of deaths, the
reduction in mortality, despite being small, might contribute
highly, in absolute terms, to the increase in LE.
Parallel results have been found in another study on avoidable
mortality in Europe that had a similar methodology.
4 That
study pinpoints Spain as being different from the rest of Europe
because of a reduction in LE in younger age groups that is
attributed to other non-avoidable causes of mortality.
4 The
reasons for the differences observed with our results is that the
European study included only those causes of avoidable
mortality that are influenced by the intervention of health
services, and also because the European study used temporary
life tables (with an upper age limit of 75 years) for all causes.
Our results show that this reduction in LE in young people is
due to the causes that are sensitive to intersector policy
interventions, and they reveal the usefulness of including this
aspect of public health in the avoidable mortality list.
Another result to be highlighted is the one observed in the
analysis of effects, which, we must remember, is a different
interpretation of the same phenomenon: the decomposition of
the changes in LE. The most important contribution to the
increase in LE was due to the indirect effect in all ages. This
means that a reduction in mortality in one age group has an
impact in that group (as measured by the direct effect) and in
other groups. Thus, the reduction in mortality as a result of
particular causes that affect mainly specific age groups (eg AIDS
or traffic accidents in young people) implies years of life gained
by these young ages, and also by other age groups, and in this
way it contributes to the increase in LE of the population as a
whole. This could be a very important argument to support
public health interventions, such as traffic regulations. The
rationale is that mortality reductions in one group affect total
life expectancy by means of other age groups.
In contrast, in older age groups, direct effect and non-
avoidable causes play a more important role. This shows that a
large proportion of the gains in LE for the whole of the
population over recent decades has been produced by an
improvement in survival for older people and this can explain,
in part, the apparent paradox in the results mentioned above. In
the definitions of avoidable mortality, most of the causes
affected by health service interventions include death only
before age 75, whereas after this age deaths are included in the
non-avoidable group. Thus, longer survival in older people
would have been the result of better health status (direct effect
means LE gains in these ages) and of better medical treatment
for avoidable causes, delaying death until after age 75. This
result supports the theory about the usefulness of extending
further the age limit used in the list of avoidable mortality.
4
The impact of avoidable mortality on life expectancy has
been previously analysed, with a different methodology, in one
region of Spain.
23 24 The impact has also been analysed for other
European countries with similar methods but using different
avoidable mortality groups,
4 9 25 26 although some of these
include causes related to health policies and causes related to
health services.
92 52 6Unfortunately, the detailed lists of causes
Figure 2 Contribution of causes and age
to the differences in life expectancy at
birth between time periods for men in
Spain between 1987 and 2001. HSI,
avoidable mortality by health service
interventions; HPI, avoidable mortality by
health policy interventions; N-AM, non-
avoidable mortality. *The numbers are the
total years of life expectancy gained due
to each group of causes of death.
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completely comparable. The problem of comparability has been
highlighted previously,
341 01 2and it is common to all studies that
have been carried out with this indicator. This drawback should
be solved by establishing a consensus on the lists of causes.
Probably, these lists should be adapted to the health situation in
each country, so that the indicator is valid in every context.
Nevertheless, common minimums (in some causes and age
groups) should be maintained so that they could be comparable
on an international level. For this reason, our work provides some
important features. On the one hand, it uses a list of causes
established by consensus in Spain for which the criteria used have
been made public and discussed among professionals in the
field.
27 28 On the other hand, it shows that making a distinction
between the causes of death to be tackled by the health system
and those needing policy interventions from other sectors gives a
new dimension to this indicator. Furthermore, the combined use
of decomposition in causes, ages and effects allows us a better
understanding ofthe impact ofavoidable mortality inthe changes
in LE experienced by the whole of the population, which could be
very useful in public health.
Funding: Instituto de Salud Carlos III, Red de centros: RCESP C03/09.
Competing interests: None.
Figure 3 Contribution of causes and age
to the differences in life expectancy at
birth between time periods for women in
Spain between 1987 and 2001. HIS,
avoidable mortality by health service
interventions; HPI, avoidable mortality by
health policy interventions; N-AM, non-
avoidable mortality. *The numbers are the
total years of life expectancy gained due
to each group of causes of death.
What this study adds
In Spain, the majority of the years of life gained or lost in young
people are a consequence of the causes that are sensitive to
intersector health policy interventions. Non-avoidable causes of
death are those producing the largest increase in LE. As the group
of non-avoidable causes results in the highest number of deaths,
the reduction in mortality, despite being small, contributes highly
to the increase in LE. By decomposing the changes in LE by
effects it is shown that the majority of the years of life gained are
due to an indirect effect. This means that the beneficial effect of
the reduced mortality at one age is responsible for the years of
life gained in other ages, and particularly in the LE of the whole
population.
Policy implications
Differences in the quality of medical care and in health policy
interventions among countries are being shown using the
‘‘avoidable mortality indicator’’. The reduction in mortality due to
these causes and its effect on the changes in LE at birth is a useful
way to evaluate the impact of these interventions on population
health. Life expectancy at birth has been increasing in recent
decades owing to the reductions in mortality for middle-aged and
older adults. Part of these changes is attributable to the contribution
of medical care and another part to health policy interventions,
which is a very important argument for public health purposes.
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